- Home
- NBIX vs KMX Comparison
NBIX vs KMX Comparison
Compare NBIX & KMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- KMX
- Stock Information
- Founded
- NBIX 1992
- KMX 1993
- Country
- NBIX United States
- KMX United States
- Employees
- NBIX N/A
- KMX N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- KMX Retail-Auto Dealers and Gas Stations
- Sector
- NBIX Health Care
- KMX Consumer Discretionary
- Exchange
- NBIX Nasdaq
- KMX Nasdaq
- Market Cap
- NBIX 11.0B
- KMX 12.5B
- IPO Year
- NBIX 1996
- KMX 1997
- Fundamental
- Price
- NBIX $87.58
- KMX $73.38
- Analyst Decision
- NBIX Buy
- KMX Buy
- Analyst Count
- NBIX 21
- KMX 11
- Target Price
- NBIX $164.80
- KMX $90.64
- AVG Volume (30 Days)
- NBIX 1.3M
- KMX 3.0M
- Earning Date
- NBIX 04-30-2025
- KMX 04-10-2025
- Dividend Yield
- NBIX N/A
- KMX N/A
- EPS Growth
- NBIX 33.20
- KMX N/A
- EPS
- NBIX 3.29
- KMX 2.93
- Revenue
- NBIX $2,355,300,000.00
- KMX $27,796,200,000.00
- Revenue This Year
- NBIX $15.48
- KMX N/A
- Revenue Next Year
- NBIX $16.18
- KMX $3.74
- P/E Ratio
- NBIX $26.38
- KMX $24.78
- Revenue Growth
- NBIX 24.81
- KMX N/A
- 52 Week Low
- NBIX $86.58
- KMX $65.83
- 52 Week High
- NBIX $157.98
- KMX $91.25
- Technical
- Relative Strength Index (RSI)
- NBIX 20.83
- KMX 42.84
- Support Level
- NBIX $113.05
- KMX $71.31
- Resistance Level
- NBIX $112.74
- KMX $82.79
- Average True Range (ATR)
- NBIX 3.20
- KMX 3.42
- MACD
- NBIX -1.46
- KMX 0.28
- Stochastic Oscillator
- NBIX 4.59
- KMX 28.11
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About KMX CarMax Inc
CarMax sells, finances, and services used and new cars through a chain of around 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue (79% in fiscal 2024 due to the chip shortage) and wholesale about 13% (19% in fiscal 2024), with the remaining portion composed of extended service plans and repair. In fiscal 2024, the company retailed and wholesaled 765,572, and 546,331 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in 2023. It seeks over 5% share a few years from now. CarMax is based in Richmond, Virginia.